Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Lau

Showing results (641-650 of 760) with videos related to

Pageof 76
Sort By:
Plos Pathogens|April 19, 2019
Distinct phenotype and function of circulating Vδ1+ and Vδ2+ γδT-cells in acute and chronic hepatitis BKyong-Mi Chang, Daniel Traum, Jang-June Park, et al.
ACS Medicinal Chemistry Letters|October 24, 2017
Stabilizing a Tubulysin Antibody-Drug Conjugate To Enable Activity Against Multidrug-Resistant TumorsLeanna R Staben, Shang-Fan Yu, Jinhua Chen, et al.
Journal of the National Cancer Institute|July 17, 2010
Randomized trial of radiotherapy plus concurrent-adjuvant chemotherapy vs radiotherapy alone for regionally advanced nasopharyngeal carcinomaAnne W M Lee, Stewart Y Tung, Daniel T T Chua, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 30, 2005
Preliminary results of a randomized study on therapeutic gain by concurrent chemotherapy for regionally-advanced nasopharyngeal carcinoma: NPC-9901 Trial by the Hong Kong Nasopharyngeal Cancer Study GroupAnne W M Lee, W H Lau, Stewart Y Tung, et al.
Archives of Internal Medicine|May 30, 2007
Evaluation of serious adverse drug reactions: a proactive pharmacovigilance program (RADAR) vs safety activities conducted by the Food and Drug Administration and pharmaceutical manufacturersCharles L Bennett, Jonathan R Nebeker, Paul R Yarnold, et al.
Science Translational Medicine|March 18, 2011
CD40 pathway activation status predicts response to CD40 therapy in diffuse large B cell lymphomaBart Burington, Peng Yue, Xiaoyan Shi, et al.
Gastroenterology|December 20, 2015
Hepatitis B Virus--Specific and Global T-Cell Dysfunction in Chronic Hepatitis BJang-June Park, David K Wong, Abdus S Wahed, et al.
The Lancet. Respiratory Medicine|October 4, 2019
Diagnostic accuracy of transbronchial lung cryobiopsy for interstitial lung disease diagnosis (COLDICE): a prospective, comparative studyLauren K Troy, Christopher Grainge, Tamera J Corte, et al.
Computers in Biology and Medicine|December 19, 2024
UniVar: A variant interpretation platform enhancing rare disease diagnosis through robust filtering and unified analysis of SNV, INDEL, CNV and SVCherie C Y Au-Yeung, Yuen-Ting Cheung, Joshua Y T Cheng, et al.
Gut|June 25, 2015
Derivation of genetic biomarkers for cancer risk stratification in Barrett's oesophagus: a prospective cohort studyMargriet R Timmer, Pierre Martinez, Chiu T Lau, et al.
Pageof 76

Showing results (641-650 of 760) with videos related to

Sort By:
Pageof 76
Plos Pathogens|April 19, 2019
Distinct phenotype and function of circulating Vδ1+ and Vδ2+ γδT-cells in acute and chronic hepatitis BKyong-Mi Chang, Daniel Traum, Jang-June Park, et al.
ACS Medicinal Chemistry Letters|October 24, 2017
Stabilizing a Tubulysin Antibody-Drug Conjugate To Enable Activity Against Multidrug-Resistant TumorsLeanna R Staben, Shang-Fan Yu, Jinhua Chen, et al.
Journal of the National Cancer Institute|July 17, 2010
Randomized trial of radiotherapy plus concurrent-adjuvant chemotherapy vs radiotherapy alone for regionally advanced nasopharyngeal carcinomaAnne W M Lee, Stewart Y Tung, Daniel T T Chua, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 30, 2005
Preliminary results of a randomized study on therapeutic gain by concurrent chemotherapy for regionally-advanced nasopharyngeal carcinoma: NPC-9901 Trial by the Hong Kong Nasopharyngeal Cancer Study GroupAnne W M Lee, W H Lau, Stewart Y Tung, et al.
Archives of Internal Medicine|May 30, 2007
Evaluation of serious adverse drug reactions: a proactive pharmacovigilance program (RADAR) vs safety activities conducted by the Food and Drug Administration and pharmaceutical manufacturersCharles L Bennett, Jonathan R Nebeker, Paul R Yarnold, et al.
Science Translational Medicine|March 18, 2011
CD40 pathway activation status predicts response to CD40 therapy in diffuse large B cell lymphomaBart Burington, Peng Yue, Xiaoyan Shi, et al.
Gastroenterology|December 20, 2015
Hepatitis B Virus--Specific and Global T-Cell Dysfunction in Chronic Hepatitis BJang-June Park, David K Wong, Abdus S Wahed, et al.
The Lancet. Respiratory Medicine|October 4, 2019
Diagnostic accuracy of transbronchial lung cryobiopsy for interstitial lung disease diagnosis (COLDICE): a prospective, comparative studyLauren K Troy, Christopher Grainge, Tamera J Corte, et al.
Computers in Biology and Medicine|December 19, 2024
UniVar: A variant interpretation platform enhancing rare disease diagnosis through robust filtering and unified analysis of SNV, INDEL, CNV and SVCherie C Y Au-Yeung, Yuen-Ting Cheung, Joshua Y T Cheng, et al.
Gut|June 25, 2015
Derivation of genetic biomarkers for cancer risk stratification in Barrett's oesophagus: a prospective cohort studyMargriet R Timmer, Pierre Martinez, Chiu T Lau, et al.
Pageof 76